Results 211 to 220 of about 2,020,825 (344)
Bond strength of aged provisional 3D-printed methacrylate resin with different surface treatments and repair materials. [PDF]
BMC Oral HealthTaokhampu N, Lekatana H, Palasuk J.
europepmc +1 more source
Molecular Oncology, EarlyView.Comprehensive cancer centre (CCCs) and CCCs of Excellence (CCCoE) integration in healthcare. Through outreach to surrounding community hospitals, CCCs enable wider access to top‐clinical cancer treatments and care, thereby facilitating the swift enrolment of patients into data‐rich clinical trials (PI‐initiated trials testing new concepts, drug ...
Anton Berns +4 more
wiley +1 more source
An in vitro study on the bond strength between composite resin and porcelain using different surface treatment and bonding methods. [PDF]
Eur J Oral SciSagen MA, Eriksen B, Moland K, Dahl BE.
europepmc +1 more source
Molecular Oncology, EarlyView.This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau +9 more
wiley +1 more source
Bonding materials for making contacts to p-type silicon [PDF]
, 1958 Donald R. Mason, John C. Sarace
openalex
Molecular Oncology, EarlyView.C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald +18 more
wiley +1 more source